Gilead GILD +0.57% Sciences recently spent about $30 million to increase its stakes in two biotech stocks.
info@pharosinv.com
+ 302106178678
Tag: $Gilead Sciences
Gilead Sciences has received a positive response from the European Medicines Agency’s Committee for Medicinal Products for Human Use on an additional indication for the use of its antibody-drug conjugate Trodelvy in certain types of pre-treated breast cancer.
PHAROS INVESTMENT ADVISORS AEEΔ
Regulated by Hellenic Capital Market Commission
with Registration Number 5/700/10.12.2014
Copyright 2023©. All Rights Reserved